Neridronic acid clinical trials
Also written Neridronate.
How each study uses neridronic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the neridronic acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 2
Grünenthal GmbH (4) · Ambros Therapeutics, Inc. (2) · Ente Ospedaliero Ospedali Galliera (1) · ASST Gaetano Pini-CTO (1)
Studies
Open first, then newest update. How each study uses neridronic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 8
- Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)RecruitingPhase 3Ambros Therapeutics, Inc.NCT07210515Written as Neridronate
- Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1RecruitingPhase 3Ambros Therapeutics, Inc.NCT07857733Written as Neridronate
- Efficacy and Safety of Intravenous Neridronic Acid in CRPSTerminatedPhase 3Grünenthal GmbHNCT03530345Written as Neridronic acid 100 mg
- Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)TerminatedPhase 3Grünenthal GmbHNCT03560986Written as Neridronic acid 100 mg
- Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TICompletedPhase 2Ente Ospedaliero Ospedali GallieraNCT01140321Written as Neridronate
- Safety of Intravenous Neridronic Acid in CRPSCompletedPhase 3Grünenthal GmbHNCT02972359Written as Neridronic acid
- Efficacy and Safety of Intravenous Neridronic Acid in CRPS-ICompletedPhase 2/3Grünenthal GmbHNCT02402530Written as Neridronic acid 62.5 mg
- Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.Status unknownPhase 2ASST Gaetano Pini-CTONCT01803360Written as Neridronate
Codes
What other systems call neridronic acid · ClinicalTrials.gg INT003341
- UNII (FDA) 8U27U3RIN4NERIDRONIC ACIDConfirmed FDA, Wikidata
- Wikidata Q1651770neridronic acidConfirmed FDA, Wikidata
- NCI Thesaurus C66230Neridronic AcidOne source FDA
- DrugBank DB11620One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8U27U3RIN4 | NERIDRONIC ACID | Confirmed FDA, Wikidata |
| Wikidata | Q1651770 | neridronic acid | Confirmed FDA, Wikidata |
| NCI Thesaurus | C66230 | Neridronic Acid | One source FDA |
| DrugBank | DB11620 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.